Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Lingying Wu"'
Autor:
Lingying Wu, Guiling Li, Xiangrong Dai, Michael Wong, Wayne Zhao, Rachel Ng, Jing Zhang, Xiaohui Yu, Yujie Li, Hongping Zhang, Yunyan Zhang, Honglin Song, Qin Xu, Qi Zhou, Danbo Wang, Li Wang, Lin Luo, Hui Qiu, Huihua Xiong, Benjamin X. Li, Jie Tang, Jusheng An
Research Protocol for the Phase I Clinical Study of the Recombinant Fully Human Anti-PD-L1 Monoclonal Antibody Socazolimab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47a3003f06f195c38cf78fc4ab9cfdcd
https://doi.org/10.1158/1078-0432.22488348
https://doi.org/10.1158/1078-0432.22488348
Autor:
Lingying Wu, Guiling Li, Xiangrong Dai, Michael Wong, Wayne Zhao, Rachel Ng, Jing Zhang, Xiaohui Yu, Yujie Li, Hongping Zhang, Yunyan Zhang, Honglin Song, Qin Xu, Qi Zhou, Danbo Wang, Li Wang, Lin Luo, Hui Qiu, Huihua Xiong, Benjamin X. Li, Jie Tang, Jusheng An
Anti-Tumor Efficacy Assessment using iRECIST criteria by IRC Evaluation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08793b12f270dca84a094cdfc7b6da3a
https://doi.org/10.1158/1078-0432.22488351
https://doi.org/10.1158/1078-0432.22488351
Autor:
Lingying Wu, Quanren Wang, Yuting Wang, Ben Zhang, Yuanguang Meng, Xin Zhang, Wenjing Hu, Jing Wang, Ge Lou, Hongyan Guo, Jianping Xiong, Wei Duan, Xiaoping Wan, Yaping Zhu, Xinfeng Yang, Ruifang An, Qiang Wu, Hongming Pan, Guiling Li, Hui Zhang, Kangsheng Gu, Shuzhong Yao, Xiaohua Wu, Rutie Yin, Li Wang, Qi Zhou, Jianqing Zhu, Jihong Liu, Hualei Bu, Ning Li
Supplementary Data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c6e93f52939dbdfca1a3b95a3461b10
https://doi.org/10.1158/1078-0432.22482597.v1
https://doi.org/10.1158/1078-0432.22482597.v1
Autor:
Lingying Wu, Quanren Wang, Yuting Wang, Ben Zhang, Yuanguang Meng, Xin Zhang, Wenjing Hu, Jing Wang, Ge Lou, Hongyan Guo, Jianping Xiong, Wei Duan, Xiaoping Wan, Yaping Zhu, Xinfeng Yang, Ruifang An, Qiang Wu, Hongming Pan, Guiling Li, Hui Zhang, Kangsheng Gu, Shuzhong Yao, Xiaohua Wu, Rutie Yin, Li Wang, Qi Zhou, Jianqing Zhu, Jihong Liu, Hualei Bu, Ning Li
Purpose:Fluzoparib (PARP inhibitor) showed promising antitumor activity for advanced ovarian cancer in a phase I study. This study aimed to assess the efficacy and safety of fluzoparib in patients with germline BRCA1/2-mutated recurrent ovarian cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28ec0f85d857a40c9a4761b5c1888014
https://doi.org/10.1158/1078-0432.c.6530961.v1
https://doi.org/10.1158/1078-0432.c.6530961.v1
Publikováno v:
Cancer Research. 82:6275-6275
Purpose:Folate Receptor Alpha (FRα) is highly expressed in multiple malignancies, including ovarian, NSCLC and breast cancer. Transient Receptor Potential Vanilloid 6(TRPV6) is upregulated in breast, ovarian and prostate cancer. However, there is no